UAL
73
3
GILD
55
5
EMC
30
-26
MAS
46
3
DFS
64
4
MO
47
6
NI
63
5
RRC
52
2
DOV
48
2
APH
53
3
MRK
25
2
GM
55
6
EQR
33
6
FAST
41
7
LEN
21
3
BF.B
35
2
ACN
54
2
BAC
38
3
PCG
59
9
AIG
38
5
UAL
73
3
GILD
55
5
EMC
30
-26
MAS
46
3
DFS
64
4
MO
47
6
NI
63
5
RRC
52
2
DOV
48
2
APH
53
3
MRK
25
2
GM
55
6
EQR
33
6
FAST
41
7
LEN
21
3
BF.B
35
2
ACN
54
2
BAC
38
3
PCG
59
9
AIG
38
5
Financhill
Back

Edesa Biotech 10K Form

Sell
19

EDSA
Edesa Biotech

Last Price:
$1.65
Seasonality Move:
-2.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EDSA News And Ratings

See the #1 stock for the next 7 days that we like better than EDSA

EDSA Financial Statistics

Sales & Book Value

Annual Sales: $328.8K
Cash Flow: $-967K
Price / Cash Flow: 0
Annual Sales: $0.61
Price / Book: 2.89

Profitability

EPS (TTM): -1.93000
Net Income (TTM): $-6.2M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Edesa Biotech Earnings Forecast

Key Edesa Biotech Financial Ratios

  • The Selling, General & Administrative Expenses for EDSA have been equal to 1,028.77% of Gross Profit Margin.
  • The Interest Expense is -0.63% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 5 years.

Edesa Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EDSA
CUSIP: 27966L
Website: edesabiotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EDSA Technical Analysis vs Fundamental Analysis

Sell
19
Edesa Biotech (EDSA) is a Sell

Is Edesa Biotech a Buy or a Sell?

  • Edesa Biotech stock is rated a Sell
    The current Edesa Biotech [EDSA] share price is $1.65. The Score for EDSA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.